Kotyark Industries shareholders approved all 12 resolutions at the company’s 10th Annual General Meeting held on August 22, 2026. The unanimous backing included a final dividend of ₹5 per equity share. Management also highlighted the company’s migration to the NSE and BSE Main Board in March 2026 and the subsequent adoption of Indian Accounting Standards (Ind AS).

The virtual meeting, chaired by Chairman cum Managing Director Gaurang Rameshchandra Shah, concluded at 12:26 pm. Scrutinizer M/s. SCS & CO LLP confirmed that promoters voted in favor of every resolution. Key management personnel, including CFO Dhruvi Mihir Shah and Non-Executive Director Bhavini Gaurang Shah, briefed members on strategic initiatives and governance updates.

Voting Results and Governance

Shareholders on record as of August 15, 2026, participated via remote e-voting and video conferencing. The company received votes from 14,682 shareholders. Promoter and promoter group entities held 64,830,744 shares and voted 100% in favor of all ordinary and special resolutions.

Statutory auditors M/s. Manubhai & Shah LLP issued an unqualified report for FY25-26. The AGM also ratified the appointment of M/s. Mittal V Kothari & Associates as secretarial auditor, despite minor annotations noted during the meeting.

Operational Highlights and Order Book

Management emphasized that FY25-26 was characterized by capacity expansion despite relatively low utilization rates, indicating substantial headroom for future growth. The company received Letters of Intent (LOIs) aggregating approximately ₹223.53 crore during the fiscal year.

Key operational developments included:

• Receipt of an OMC order worth ₹173.45 crore in FY26-27.
• Establishment of a dedicated Glycerine Processing Unit at Sirohi to target pharmaceutical, food, and personal care sectors.
• Successful testing and durability trials of B20 and B30 biodiesel blends by the Automotive Research Association of India (ARAI).
• Achievement of ISO 9001:2015 certification for quality management systems covering Bio Diesel and Crude Glycerine manufacture.

Strategic Outlook and CSR

Chairman Gaurang Rameshchandra Shah outlined priorities for FY26-27, targeting a capacity utilization increase to 60-70% over the next two to three years. The company aims to broaden its customer base across OMC, industrial, and bulk channels. Its business model relies on waste and non-edible feedstock, supported by a Zero Effluent Discharge model.

The company earned approval for 57,874 Carbon Credits under the Verra standard for the period September 15, 2020, to March 31, 2022. Additionally, Kotyark incurred ₹46.55 lakhs towards Corporate Social Responsibility (CSR) activities during FY25-26. Non-Executive Director Bhavini Gaurang Shah noted that Chairman Gaurang Rameshchandra Shah received a Certificate of Excellence from the World Book of Records in London in June 2026 for his contributions to renewable energy.

What the Numbers Show

The receipt of a single OMC order worth ₹173.45 crore constitutes approximately 78% of the total ₹223.53 crore in LOIs received during FY25-26. This concentration highlights the company’s growing dependency on large-scale institutional buyers rather than fragmented retail or small industrial clients for near-term revenue realization.

Kotyark Industries has received a significant order worth Rs 173.45 crore from Indian Oil Corporation (IOCL), Bharat Petroleum Corporation Limited (BPCL), and Hindustan Petroleum Corporation Limited (HPCL). The order is for biodiesel allocation for supplies in Gujarat during June–August 2026, pursuant to an OMC tender. The scheduled supply period is 92 days from the date of award of the contract. The company's market capitalisation currently stands at Rs 475 crores.

Prior to this large order, Kotyark Industries had also received Letters of Intent (LOIs) worth Rs 15.41 crore from BPCL and HPCL for biodiesel supply. That award represents a pre-contract stage, with revenue recognition commencing only after formal work order issuance. Together, these disclosures reflect a meaningful build-up in the company's order pipeline from public sector oil marketing companies (OMCs).

Order in Financial Context

The Rs 173.45 crore order value represents approximately 267.50% of the company's average quarterly revenue of Rs 64.83 crore. The total visible order book, including the Rs 15.41 crore LOI, stands at Rs 188.86 crore. The trailing twelve-month revenue stands at Rs 259.30 crore. The order book coverage is approximately 2.68 quarters of average quarterly revenue based on the primary order alone. As this is a confirmed order linked to an OMC tender, it represents a tangible step towards revenue recognition upon execution of the supply schedule.

The following table summarises the recent order disclosures:

Company Order Track Record

The company has disclosed two notable orders in the recent period. The order history table below summarises the inflows:

These disclosures make the current biodiesel supply agreements the primary drivers of the visible order book in the recent past, with no other order disclosures found in Q4FY26, Q3FY26, or Q4FY25.

Execution and Revenue Quality

Kotyark Industries has demonstrated improving profitability metrics in recent quarters. In Q4FY26, the company reported revenue of Rs 63.70 crore and net profit of Rs 9.40 crore, with an operating profit margin (OPM) of 30.07%. This marks an improvement from Q3FY26, where revenue was Rs 103.90 crore but OPM compressed to 9.52% due to lower operating profit of Rs 9.90 crore. In Q4FY25, revenue was Rs 20.20 crore with an OPM of 28.20%.

The high OPM in Q4FY26 suggests improved execution efficiency or a favorable product mix, although the absolute revenue run-rate remains volatile quarter-on-quarter.

Revenue Growth

Kotyark Industries' annual revenue has grown from Rs 288.80 crore in FY25 to Rs 314.90 crore in FY26, representing a year-on-year (YoY) growth of +9.00%. This growth trajectory followed a substantial jump of +107.60% in FY24, indicating periods of rapid expansion interspersed with more moderate growth phases.

Working Capital and Execution Capacity

The company's balance sheet appears robust for executing new contracts. The current ratio stands at 3.22x, indicating ample liquidity to manage working capital requirements for the upcoming biodiesel supply. Total Liabilities/Equity is low at 0.43x, suggesting minimal financial leverage. However, operating cashflow was negative at -Rs 3.90 crore in FY26, compared to positive Rs 30.90 crore in FY25. This negative cash conversion warrants monitoring to ensure that receivables from clients like IOCL, BPCL, and HPCL do not stretch the working capital cycle as volumes increase.

What to Watch

• Supply Execution: Monitor the commencement of biodiesel supplies scheduled within 92 days of award and the subsequent revenue recognition.
• LOI Conversion: Track whether the Rs 15.41 crore LOI from BPCL and HPCL converts into formal work orders and eventual revenue.
• Execution Rate: Monitor whether the Q4FY26 revenue momentum of Rs 63.70 crore can be sustained, given the volatility seen in Q3FY26 and Q4FY25.
• Cash Conversion: With negative operating cashflow in FY26, watch for improvements in days sales outstanding (DSO) as the company scales up biodiesel supplies.
• Client Concentration: IOCL, BPCL, and HPCL are major public sector undertakings; securing their business reduces customer acquisition risk but may introduce payment cycle delays typical of large PSUs.

Key Observations

• Contract progression: The filing confirms a large order value of Rs 173.45 crore from IOCL, BPCL, and HPCL for biodiesel supplies in Gujarat. Revenue recognition will depend on the actual supply volumes delivered within the 92-day window scheduled for June–August 2026.
• Pre-contract pipeline: The Rs 15.41 crore LOI from BPCL and HPCL adds to the near-term order pipeline, pending formal work order issuance.
• Valuation check (as of 12 Aug 2026): P/E of 24.80x against ROCE of 17.25%. Valuation appears to be pricing in execution improvement not yet fully visible in return ratios, though the gap is moderate. MCap stands at Rs 475 crores.
• Promoter holding: Moved from 63.84% in Q4FY26 to 57.34% in Q1FY27, a 6.50 pp reduction. This selling activity by promoters should be monitored for further dilution or strategic shifts.
• Cash conversion: Operating cashflow of -Rs 3.90 crore in FY26; backlog is not converting to cash efficiently, and receivables or working capital cycle may be stretched despite strong profitability on paper.